Harel Insurance Investments & Financial Services Ltd. Vertex Pharmaceuticals Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 5,165 shares of VRTX stock, worth $2.11 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,165

Previous 11,942 56.75%

Holding current value

$2.11 Million

Previous $5.63 Million 57.3%

% of portfolio

0.04%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$460.0 - $505.78 $3.12 Million - $3.43 Million	-6,777 Reduced 56.75%	5,165 $2.4 Million
Q2 2024 Jul 22, 2024	BUY	$392.81 - $485.53 $169,693 - $209,748	432 Added 3.75%	11,942 $5.63 Million
Q1 2024 Apr 30, 2024	BUY	$407.69 - $446.08 $575,658 - $629,864	1,412 Added 13.98%	11,510 $4.81 Million
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $1.63 Million - $1.95 Million	4,758 Added 89.1%	10,098 $4.12 Million
Q3 2023 Oct 30, 2023	SELL	$338.18 - $362.46 $1.66 Million - $1.78 Million	-4,918 Reduced 47.94%	5,340 $1.88 Million
Q2 2023 Jul 17, 2023	BUY	$314.42 - $351.91 $2.21 Million - $2.47 Million	7,023 Added 217.09%	10,258 $3.57 Million
Q1 2023 May 02, 2023	BUY	$283.23 - $323.1 $189,480 - $216,153	669 Added 26.07%	3,235 $1.01 Million
Q4 2022 Jan 26, 2023	SELL	$285.76 - $321.48 $38,863 - $43,721	-136 Reduced 5.03%	2,566 $740,000
Q3 2022 Oct 31, 2022	BUY	$273.83 - $305.53 $630,082 - $703,024	2,301 Added 573.82%	2,702 $791,000
Q2 2022 Jul 19, 2022	BUY	$234.96 - $292.55 $12,217 - $15,212	52 Added 14.9%	401 $113,000
Q1 2022 May 03, 2022	BUY	$221.42 - $260.97 $77,275 - $91,078	349 New	349 $91,000
Q3 2021 Oct 25, 2021	SELL	$181.39 - $202.99 $104,843 - $117,328	-578 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$187.49 - $221.1 $54,559 - $64,340	-291 Reduced 33.49%	578 $380,000
Q1 2021 Apr 27, 2021	SELL	$207.02 - $241.31 $641,554 - $747,819	-3,099 Reduced 78.1%	869 $624,000
Q4 2020 Jan 26, 2021	BUY	$207.01 - $276.09 $125,034 - $166,758	604 Added 17.95%	3,968 $3.02 Million
Q3 2020 Oct 20, 2020	BUY	$255.65 - $303.1 $681,051 - $807,458	2,664 Added 380.57%	3,364 $915,000
Q2 2020 Jul 14, 2020	BUY	$225.48 - $295.8 $157,836 - $207,060	700 New	700 $203,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account

Harel Insurance Investments & Financial Services Ltd. Vertex Pharmaceuticals Inc Transaction History